Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Aug 8 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.49                9.18             48.90    
                 (-7.4 pct)          (-34.9 pct)      (+12.4 pct) 
  Operating       loss 1.63            423 mln            5.00    
                                     (-90.7 pct)      (+66.5 pct) 
  Recurring       loss 1.50            509 mln            5.20    
                                     (-88.9 pct)      (+52.7 pct) 
  Net             loss 1.05            319 mln            3.40    
                                     (-91.8 pct)     (+129.6 pct) 
  EPS           loss 8.70 yen         2.65 yen         28.24 yen  
  Ann Div                             17.00 yen        17.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             17.00 yen        17.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news